The Allergan board selected former Celgene CEO and Chairman Bob Hugin to serve on its board of directors, effective Feb. 19.
Mr. Hugin worked at Celgene for 19 years and helped oversee the expansion of Celgene from a U.S.-based company into a global company with operations across 50 countries.
"Bob is an industry leader with deep operational, financial and commercial experience that is relevant to Allergan's business and strategy," said Brent Saunders, Allergan chairman and CEO. "He has a strong track record of developing innovative therapies, delivering strong business results and creating shareholder value. I look forward to working with Bob and to Allergan benefitting from his expertise."
More articles on pharmacy:
23andMe wants to become a drug company, has 13 drugs in its pipeline: 5 notes
J&J CEO on partnership with Apple: 'We're going to save lives'
Medicare would pay for CAR-T therapy under new proposal